ICU
Price
$0.77
Change
-$0.01 (-1.28%)
Updated
Jul 25 closing price
Capitalization
17.41M
NBY
Price
$0.67
Change
+$0.02 (+3.08%)
Updated
Jul 25 closing price
Capitalization
3.91M
Interact to see
Advertisement

ICU vs NBY

Header iconICU vs NBY Comparison
Open Charts ICU vs NBYBanner chart's image
SeaStar Medical Holding
Price$0.77
Change-$0.01 (-1.28%)
Volume$1.09M
Capitalization17.41M
NovaBay Pharmaceuticals
Price$0.67
Change+$0.02 (+3.08%)
Volume$118.09K
Capitalization3.91M
ICU vs NBY Comparison Chart in %
Loading...
ICU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICU vs. NBY commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICU is a StrongBuy and NBY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (ICU: $0.77 vs. NBY: $0.67)
Brand notoriety: ICU and NBY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICU: 11% vs. NBY: 342%
Market capitalization -- ICU: $17.41M vs. NBY: $3.91M
ICU [@Biotechnology] is valued at $17.41M. NBY’s [@Biotechnology] market capitalization is $3.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICU’s FA Score shows that 0 FA rating(s) are green whileNBY’s FA Score has 2 green FA rating(s).

  • ICU’s FA Score: 0 green, 5 red.
  • NBY’s FA Score: 2 green, 3 red.
According to our system of comparison, NBY is a better buy in the long-term than ICU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICU’s TA Score shows that 4 TA indicator(s) are bullish while NBY’s TA Score has 4 bullish TA indicator(s).

  • ICU’s TA Score: 4 bullish, 3 bearish.
  • NBY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ICU is a better buy in the short-term than NBY.

Price Growth

ICU (@Biotechnology) experienced а +8.62% price change this week, while NBY (@Biotechnology) price change was +1.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICU($17.4M) has a higher market cap than NBY($3.91M). NBY YTD gains are higher at: 11.876 vs. ICU (-60.263). NBY has higher annual earnings (EBITDA): -6.8M vs. ICU (-15.79M). NBY has more cash in the bank: 8.47M vs. ICU (5.3M). ICU has less debt than NBY: ICU (363K) vs NBY (1.13M). NBY has higher revenues than ICU: NBY (9.78M) vs ICU (428K).
ICUNBYICU / NBY
Capitalization17.4M3.91M445%
EBITDA-15.79M-6.8M232%
Gain YTD-60.26311.876-507%
P/E RatioN/A0.03-
Revenue428K9.78M4%
Total Cash5.3M8.47M63%
Total Debt363K1.13M32%
FUNDAMENTALS RATINGS
NBY: Fundamental Ratings
NBY
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
38
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ICUNBY
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
53%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
49%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
57%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
46%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
41%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
67%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
86%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ICU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCTO2.461.03
+72.03%
Eightco Holdings Inc
CAC41.000.05
+0.12%
Camden National Corp
AACI10.09N/A
N/A
Armada Acquisition Corp II
TWLO131.07-0.60
-0.46%
Twilio
XPRO8.65-0.26
-2.92%
Expro Group Holdings NV

ICU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICU has been closely correlated with NCNA. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICU jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICU
1D Price
Change %
ICU100%
-1.04%
NCNA - ICU
83%
Closely correlated
+10.37%
CDTX - ICU
83%
Closely correlated
-1.54%
TAOX - ICU
83%
Closely correlated
-5.51%
NBY - ICU
83%
Closely correlated
+3.23%
WINT - ICU
82%
Closely correlated
-3.92%
More

NBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, NBY has been closely correlated with CDTX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NBY jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBY
1D Price
Change %
NBY100%
+3.23%
CDTX - NBY
93%
Closely correlated
-1.54%
NCNA - NBY
93%
Closely correlated
+10.37%
WINT - NBY
92%
Closely correlated
-3.92%
TAOX - NBY
91%
Closely correlated
-5.51%
RNAC - NBY
91%
Closely correlated
-0.97%
More